Neurofibroma classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(8 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}}{{S.M.}}
{{CMG}}; {{AE}}{{S.M.}}
==Overview==
==Overview==
[[Neurofibroma]] may be [[Classification|classified]] into 5 subtypes: [[cutaneous]]/[[dermal]]/[[Localized disease|localized]], [[subcutaneous]], [[diffuse]], [[intramuscular]], and [[plexiform neurofibroma]]. [[Plexiform neurofibroma|Plexiform neurofibromas]] may be further [[Subclass (biology)|sub-classified]] into [[diffuse]] and [[nodular]] [[Plexiform neurofibroma|plexiform]].
[[Neurofibroma]] may be [[Classification|classified]] into 5 subtypes: [[cutaneous]]/[[dermal]]/[[Localized disease|localized]], localized intraneural, [[subcutaneous]], [[diffuse]], [[intramuscular]], [[Plexiform neurofibroma|plexiform]] and [[Pigmented lesions|pigmented]] [[neurofibroma]]. [[Plexiform neurofibroma|Plexiform neurofibromas]] may be further [[Subclass (biology)|sub-classified]] into [[diffuse]] and [[nodular]] [[Plexiform neurofibroma|plexiform]].


==Classification==
==Classification==
[[Neurofibroma]] may be [[Classification|classified]] into following subtypes:<ref name="libre">Neurofibroma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Neurofibroma#cite_note-pmid15486243-2 Accessed on November 17, 2015 </ref><ref>http://www.nfmidwest.org/wp-content/uploads/2016/03/Neurofibromas.pdf</ref><ref>https://pubs.rsna.org/doi/10.1148/rg.24si035170#REF8</ref><ref>http://surgpathcriteria.stanford.edu/peripheral-nerve/neurofibroma/</ref>
[[Neurofibroma]] may be [[Classification|classified]] into following subtypes:<ref name="WilkinsonManson2004">{{cite journal|last1=Wilkinson|first1=Lana M.|last2=Manson|first2=David|last3=Smith|first3=Charles R.|title=Best Cases from the AFIP|journal=RadioGraphics|volume=24|issue=suppl_1|year=2004|pages=S237–S242|issn=0271-5333|doi=10.1148/rg.24si035170}}</ref><ref>https://pubs.rsna.org/doi/10.1148/rg.24si035170#REF8</ref>
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 12: Line 12:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Characteristics/Description
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Characteristics/Description
|-
|-
| style="background:#DCDCDC;" align="center" + |'''[[Cutaneous]]/[[Dermal]]/[[Localized disease|Localized]]/Sporadic neurofibroma''' (90%)
| style="background:#DCDCDC;" align="center" + |'''[[Cutaneous]]/[[Dermal]]/[[Localized disease|Localized]]/Sporadic [[neurofibroma]]''' (90%)
|
|
* Most common type
* Most common type
* Circumscribed but not [[Encapsulated organisms|encapsulated]]
* Circumscribed but not [[Encapsulated organisms|encapsulated]]
* Permeative growth in nerve quickly proceeds to diffuse infiltration of surrounding soft tissue
* Permeative [[growth]] in [[nerve]] quickly proceeds to [[diffuse]] [[Infiltration (medical)|infiltration]] of surrounding [[soft tissue]]
* Occurs as lumps or bumps on skin
* Occurs as [[Lump|lumps]] or [[bumps on skin]]
* Painless
* Painless
* Slowly growing
* Slowly [[Growth|growing]]
* Often in [[dermis]] and [[subcutaneous]]  
* Often in [[dermis]] and [[subcutaneous]]  
* ≤2-5 cm in diameter
* ≤2-5 cm in [[diameter]]
* Arise from [[Cutaneous nerve|small cutaneous nerves]]
* Arise from [[Cutaneous nerve|small cutaneous nerves]]
* Overrun [[axons]] may be identified within
* Overrun [[axons]] may be identified within
* May contain fat
* May contain [[fat]]
* Starts in teenage years or young adults and rarely starts in childhood
* Starts in teenage years or [[young adults]] and rarely starts in [[childhood]]
* Increases in size and number over the years
* Increases in size and [[number]] over the years
* Clearly defined borders hence, can be removed if necessary
* Clearly defined borders hence, can be removed if [[Necessary and sufficient|necessary]]
* Number of skin tumors in each patient varies tremendously
* [[Number]] of [[skin]] [[tumors]] in each [[patient]] varies tremendously
* Mostly solitary and sporadic, not associated with [[NF1]]
* Mostly [[solitary]] and sporadic, not associated with [[NF1]]
* [[Malignant]] transformation very rare
* [[Malignant]] [[transformation]] very rare
|-
|-
| style="background:#DCDCDC;" align="center" + |'''Localized Intraneural neurofibroma'''
| style="background:#DCDCDC;" align="center" + |'''Localized Intraneural [[neurofibroma]]'''
|
|
* Second-most common type
* Second-most common type
* Segmental, fusiform nerve enlargement
* [[Segmental analysis (biology)|Segmental]], [[fusiform]] [[nerve]] enlargement
* Residual [[axons]] traverse through lesion
* [[Residual]] [[axons]] traverse through [[lesion]]
** Neurofilament [[immunohistochemistry]] and Bielshowsky stain show axons within center of lesion
** [[Neurofilament]] [[immunohistochemistry]] and Bielshowsky [[stain]] show [[axons]] within center of lesion
* Often contains coarse, refractile [[collagen]]
* Often contains coarse, refractile [[collagen]]
* [[Malignant]] change infrequent
* [[Malignant]] [[Change detection|change]] infrequent
|-
|-
| style="background:#DCDCDC;" align="center" + |[[Subcutaneous|'''Subcutaneous''']] '''neurofibroma'''
| style="background:#DCDCDC;" align="center" + |[[Subcutaneous|'''Subcutaneous''']] '''[[neurofibroma]]'''
|
|
* Common
* Common
Line 48: Line 48:
* They are often a form of [[Plexiform neurofibroma|plexiform neurofibromas]]
* They are often a form of [[Plexiform neurofibroma|plexiform neurofibromas]]
|-
|-
| style="background:#DCDCDC;" align="center" + |[[Diffuse|'''Diffuse''']] '''neurofibroma'''
| style="background:#DCDCDC;" align="center" + |[[Diffuse|'''Diffuse''']] '''[[neurofibroma]]'''
'''(superficial)'''
'''([[superficial]])'''
|
|
* [[Superficial]]
* [[Superficial]]
* Uncommon
* Uncommon
* Feels soft and squishy
* Feels [[Soft tissue|soft]] and squishy
* Most common in head (scalp) and neck region or trunk (often protruding out, like a “love handle”)
* Most common in [[head]] ([[scalp]]) and [[neck]] region or [[trunk]] (often protruding out, like a “[[Love handles|love handle]]”)
* Ill defined margins, can't tell where tumor stops
* Ill defined margins, can't tell where [[tumor]] stops
* Runs through the full [[skin]] thickness (from the surface all the way down to the base of the skin ([[subcutaneous]] fascia/fat)
* Runs through the full [[skin]] thickness (from the [[Surface anatomy|surface]] all the way down to the [[base]] of the [[skin]] ([[subcutaneous]] [[fascia]]/[[fat]])
* Doesn't go deeper than [[Tenon's capsule|fascia]]
* Doesn't go deeper than [[Tenon's capsule|fascia]]
* Nondestructive, envelops normal structures (e.g., fat cells and adenexal structures)
* [[Nondestructive testing|Nondestructive]], [[Envelope (biology)|envelops]] normal [[Structure factor|structures]] (e.g., [[fat cells]] and adenexal [[Structure factor|structures]])
* Uniform matrix of fine, [[Collagen|fibrillary collagen]]
* Uniform [[matrix]] of fine, [[Collagen|fibrillary collagen]]
* Shorter, rounder [[Schwann cells]]
* Shorter, rounder [[Schwann cells]]
* Clusters of pseudo-meissnerian body-like structures may be seen
* [[Cluster (epidemiology)|Clusters]] of pseudo-meissnerian [[body]]-like structures may be seen
* Usually seen in early childhood and young adults
* Usually seen in early [[childhood]] and [[young adults]]
* Usually associated with diffuse [[hyperpigmentation]], so looks like a very large squishy [[café au lait spot]]
* Usually associated with [[diffuse]] [[hyperpigmentation]], so looks like a very large squishy [[café au lait spot]]
* Solitary lesions and not related to any inherited condition (rarely associated with [[NF1]])
* [[Solitary]] [[lesions]] and not related to any [[inherited]] [[condition]] (rarely associated with [[NF1]])
* Rare malignant change
* Rare [[malignant]] [[Change detection|change]]
|-
|-
| style="background:#DCDCDC;" align="center" + |[[Intramuscular|'''Intramuscular''']] '''neurofibroma'''
| style="background:#DCDCDC;" align="center" + |[[Intramuscular|'''Intramuscular''']] '''[[neurofibroma]]'''
|
|
* Common
* Common
* Usually isolated [[tumors]] in the [[muscle]]
* Usually isolated [[tumors]] in the [[muscle]]
* Growths along very small nerves
* [[Growth|Growths]] along very small [[nerves]]
* Causes pain sometimes
* Causes [[pain]] sometimes
* Can be removed  (leaves a scar behind)
* Can be removed  (leaves a [[scar]] behind)
* Sometimes can occur as [[Plexiform neurofibroma|plexiform neurofibromas]] in form of chains or networks
* Sometimes can occur as [[Plexiform neurofibroma|plexiform neurofibromas]] in form of [[Chain (sequence)|chains]] or [[Network effect|networks]]
|-
|-
| style="background:#DCDCDC;" align="center" + |'''[[Plexiform neurofibroma|Plexiform]] neurofibroma'''
| style="background:#DCDCDC;" align="center" + |'''[[Plexiform neurofibroma|Plexiform neurofibroma]]'''
'''(deep)'''
'''(deep)'''
|
|
* Deep
* Deep
* Associated with [[NF1]]
* Associated with [[NF1]]
* Diffuse involvement along a large nerve and its branches
* [[Diffuse]] involvement along a large [[nerve]] and its [[Branches of medicine|branches]]
* Mostly internal/ intraneural
* Mostly [[internal]]/ intraneural
* Can also involve small nerves and superficial skin
* Can also involve small [[nerves]] and [[superficial]] [[skin]]
* Have more [[connective tissue]]/extracellular matrix than cutaneous [[Neurofibroma|neurofibromas]], that separates the [[nerve fibers]]
* Have more [[connective tissue]]/[[extracellular matrix]] than [[cutaneous]] [[Neurofibroma|neurofibromas]], that separates the [[nerve fibers]]
* Gross enlargement of the nerve with nodular tumor development results in the gross pathologic appearance referred to as “bag of worms”
* [[Gross]] enlargement of the [[nerve]] with [[nodular]] [[tumor]] [[development]] results in the [[gross]] [[Pathological|pathologic]] [[appearance]] referred to as “bag of worms”
* Generally believed to be present at [[birth]] (congenital)
* Generally believed to be present at [[birth]] ([[congenital]])
* Disfiguring
* Disfiguring
* Affects function due to sheer size as well as neurovascular compromise
* Affects [[Function (biology)|function]] due to sheer size as well as [[Neurovascular bundle|neurovascular]] compromise
* Upto 5% risk of malignant transformation
* Upto 5% risk of [[malignant]] [[transformation]]
*Plexiform neurofibroma exhibits following features on T2-weighted MRI:
*[[Plexiform neurofibroma]] exhibits following [[Features (pattern recognition)|features]] on T2-weighted [[Magnetic resonance imaging|MRI]]:
**Target sign (low signal intensity centrally with a ring of high signal intensity peripherally)
**Target [[Sign (medicine)|sign]] (low [[Signal (biology)|signal]] [[intensity]] centrally with a ring of high [[Signal (biology)|signal]] [[intensity]] peripherally)
**Fascicular sign
**Fascicular [[Sign (medical)|sign]]
**May appear as a larger and more infiltrating mass with lobulated borders with inhomogeneous enhancement
**May [[Appearance|appear]] as a larger and more [[Infiltration (medical)|infiltrating]] [[mass]] with lobulated borders with inhomogeneous enhancement
|-
|-
| style="background:#DCDCDC;" align="center" + |'''Pigmented neurofibroma'''  
| style="background:#DCDCDC;" align="center" + |'''[[Pigmented lesions|Pigmented]] [[neurofibroma]]'''  
|
|
* Neurofibroma with melanin-bearing pigmented cells, usually only appreciated microscopically
* [[Neurofibroma]] with [[melanin]]-bearing [[Pigmented Lesions|pigmented]] [[Cells (biology)|cells]], usually only appreciated [[Microscopic|microscopically]]
* Not considered a true subtype
* Not considered a true subtype
* No increased risk of malignant transformation
* No increased risk of [[Malignancy|malignan]]<nowiki/>t [[transformation]]
|}
|}


[[Plexiform neurofibroma|Plexiform neurofibromas]] can be further [[Subclass (biology)|subclassified]] into following:<ref>http://www.nfmidwest.org/wp-content/uploads/2016/03/Neurofibromas.pdf</ref>
[[Plexiform neurofibroma|Plexiform neurofibromas]] can be further [[Subclass (biology)|subclassified]] into following:
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 108: Line 108:
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Characteristics/Description
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Characteristics/Description
|-
|-
| style="background:#DCDCDC;" align="center" + |'''[[Diffuse]] [[Plexiform neurofibroma|Plexiform]] neurofibroma'''
| style="background:#DCDCDC;" align="center" + |'''[[Diffuse]] [[Plexiform neurofibroma|Plexiform neurofibroma]]'''
|
|
* It extends through the [[skin]] into [[fascia]] and [[muscle]]
* It [[extends]] through the [[skin]] into [[fascia]] and [[muscle]]
* Lacks clear margins
* [[Lack (manque)|Lacks]] clear margins
* Has “little [[fingers]]” that invade [[muscle]] or other [[Tissue (biology)|tissue]]
* Has “little [[fingers]]” that invade [[muscle]] or other [[Tissue (biology)|tissue]]
* May not be easy to see in infants
* May not be easy to see in [[infants]]
* May have a large [[café au lait spot]] “above” it
* May have a large [[café au lait spot]] “above” it
|-
|-
| style="background:#DCDCDC;" align="center" + |'''[[Nodular]] [[Plexiform neurofibroma|Plexiform]] neurofibroma'''
| style="background:#DCDCDC;" align="center" + |'''[[Nodular]] [[Plexiform neurofibroma|Plexiform neurofibroma]]'''
|
|
* Usually involves [[nerves]] coming off the [[spinal cord]] or off of larger [[nerves]] (such as [[sciatic nerve]])
* Usually involves [[nerves]] coming off the [[spinal cord]] or off of larger [[nerves]] (such as [[sciatic nerve]])

Latest revision as of 15:45, 1 November 2019

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma classification

CDC on Neurofibroma classification

Neurofibroma classification in the news

Blogs on Neurofibroma classification

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Neurofibroma may be classified into 5 subtypes: cutaneous/dermal/localized, localized intraneural, subcutaneous, diffuse, intramuscular, plexiform and pigmented neurofibroma. Plexiform neurofibromas may be further sub-classified into diffuse and nodular plexiform.

Classification

Neurofibroma may be classified into following subtypes:[1][2]

Types of neurofibromas Characteristics/Description
Cutaneous/Dermal/Localized/Sporadic neurofibroma (90%)
Localized Intraneural neurofibroma
Subcutaneous neurofibroma
Diffuse neurofibroma

(superficial)

Intramuscular neurofibroma
Plexiform neurofibroma

(deep)

Pigmented neurofibroma

Plexiform neurofibromas can be further subclassified into following:

Types of neurofibromas Characteristics/Description
Diffuse Plexiform neurofibroma
Nodular Plexiform neurofibroma

References

  1. Wilkinson, Lana M.; Manson, David; Smith, Charles R. (2004). "Best Cases from the AFIP". RadioGraphics. 24 (suppl_1): S237–S242. doi:10.1148/rg.24si035170. ISSN 0271-5333.
  2. https://pubs.rsna.org/doi/10.1148/rg.24si035170#REF8


Template:WikiDoc Sources